Outpatient gamete intrafallopian transfer: a clinical analysis of 710 cases.
From February 1986 to June 1989 445 infertile couples were treated with a total of 710 treatment cycles involving laparoscopic gamete intrafallopian transfer (GIFT). The median age of the female partner was 33.5 years (range, 24 to 49 years) and the median duration of infertility was 4 years (range, 2 to 20 years). The final outcome of all 217 clinical pregnancies is known. There were 150 live births among which all but one baby survived, comprising 112 singleton births, 28 twin births, nine triplet births and one quadruplet birth. There were no still births, but there were two premature, multiple live births (one triplet, one quadruplet) among which no babies survived the neonatal period. Overall, 40 of the 152 potentially viable pregnancies were multiple (26.3%). Three of 206 potentially viable babies were born with congenital anomalies (1.5%). There were 50 clinical spontaneous abortions (24.8% of uterine pregnancies), one termination of pregnancy for Down's syndrome, and 14 ectopic pregnancies rate was 30.6% per laparoscopy and, among 740 initiated cycles, a live and surviving birth-per-initiated-cycle rate of 20.2%, or 33.7% to date per couple entering the programme. The 710 laparscopies resulted in two serious complications (0.3%), one of which required laparotomy. Eight other patients were admitted to hospital for rest and observation because of painful ovarian enlargement in the luteal phase. The total inpatient admission rate was 1.4%. Outpatient laparoscopic GIFT under general anaesthesia is a safe and effective procedure when conventional treatment for infertility has been unsuccessful.
Jansen
R P
RP
Sydney IVF, NSW.
Anderson
J C
JC
Birrell
W S
WS
Lyneham
R C
RC
Sutherland
P D
PD
Turner
M
M
Flowers
D
D
Ciancaglini
E
E
D000022:Abortion, Spontaneous / Q000453:epidemiology; D000328:Adult; D000553:Ambulatory Care; D000013:Congenital Abnormalities / Q000453:epidemiology; D005260:Female; D005498:Follicular Phase / Q000502:physiology; D015181:Gamete Intrafallopian Transfer; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D010535:Laparoscopy / Q000009:adverse effects; D016729:Leuprolide; D008183:Luteal Phase / Q000502:physiology; D008423:Maternal Age; D008875:Middle Aged; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D011374:Progesterone / Q000008:administration & dosage; D011446:Prospective Studies
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D016729:Leuprolide